On November 25th, CIBER-BBN organized a new webinar on regulatory aspects of in vitro diagnistic (IVD) medical devices.
The European Parliament, in 2016, approved the new regulations that redefined the development of In Vitro Diagnostic (IVD) methods, with the aim of providing a framework of greater safety and transparency for patients, and at the same time renewing the regulations in force in that moment.
This conference is aimed at researchers from the Academy, or any professional interested in clarifying the most important changes in regulations for the development of IVD products. We will have the participation of experts from the national competent authority, and several companies that will explain their experience to bring this type of product to market. Among them: Ramón Martínez Máñez Scientific Director of NANBIOSIS Unit 26 NMR: Biomedical Applications II and Laura Lechuga, Scientific Director of U4 Biodeposition and Biodetection Unit
Registration and program here.